RecruitingNCT05315141

Multicenter Cohort Study of AAV in Hunan of China

Multicenter Cohort Study of ANCA-associated Small Vasculitis in Hunan Province of China

Sponsor

Xiangya Hospital of Central South University

Enrollment

500 participants

Start Date

Mar 16, 2022

Study Type

OBSERVATIONAL

Conditions

ANCA-associated Vasculitis

Summary

This study aimed to explore the incidence of Anti-neutrophil cytoplasmic antibody (ANCA）-associated vasculitis (AAV) progression and its association with adverse consequences. It will enroll approximately 500 AAV patients in Hunan province of China and follow-up for at least 5 years. Demographic characteristics, clinical and laboratory data will be collected at baseline and every follow-up. The principal clinical outcomes of the study consist of end stage renal disease (ESRD) and death.

Eligibility

Plain Language Summary

Simplified for easier understanding

This is an observational cohort study in Hunan, China that tracks patients diagnosed with ANCA-associated vasculitis (AAV) — a rare autoimmune disease where the immune system attacks blood vessels, often affecting the kidneys and lungs. The study aims to better understand the disease progression and treatment outcomes in the Chinese population. **You may be eligible if...** - You have been diagnosed with ANCA-associated vasculitis according to 2012 classification criteria - You are willing to sign an informed consent form **You may NOT be eligible if...** - You refuse to sign the informed consent form Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.